Thermo Fisher: UBS downgrades to 'Neutral' Rating, The Target Price is $460

UBS downgrades 'Neutral' rating on Thermo Fisher(TMO), compare with the 'Buy' previously.

The target price is $460, compare with $500 previously.

[Recent Rating]

Date	Agency	Change	Rating	Rating （previously）	Target Price	Target Price（previously）
2025-07-09	UBS	Downgrades	Neutral	Buy	$460	$500
2025-07-08	Evercore ISI Group	Maintains	Outperform	Outperform	$480	$500
2025-06-24	Barclays	Maintains	Equal-Weight	Equal-Weight	$450	$475

[Company Profile] Thermo Fisher Scientific Inc. is a Delaware corporation. The company is the world leader in serving science. The company Mission is to enable customers to make the world healthier, cleaner and safer. The company serve customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. The company global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.